Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial

著者: Armin Ghobadi, Veronika Bachanová, Krish Patel, Jae H. Park, Ian W. Flinn, Peter A. Riedell, Carlos Bachier, Catherine Diefenbach, Carol Wong, Cara Bickers, Lilly Wong, Deepa Patel, Jode Goodridge, Matthew Denholt, Bahram Valamehr, Rebecca Elstrom, Paolo Strati - The Lancet 2025 被引用: 113